← All diseases Liver, kidneys and digestion

Primary biliary cholangitis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest evidence only (95)Meta-analysis (34)Treatment guideline (10)Randomized trial (22)Phase 3 Study (15)Systematic review (14)Clinical examination (354)Review article (274)Early study (phase 1 or 2) (18)Case reports (145)Laboratory or animal study (50)Commentary or editorial (39)Retracted publication (2) Studies currently recruiting participants only (32)

Filter

Publications and studies (1840)

• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Cholelithiasis and Biliary Cirrhosis in a 28-Year-Old Man. (2017/05/01) ♡
• Apamin suppresses biliary fibrosis and activation of hepatic stellate cells. (2017/05/01) ♡
• Ursodeoxycholic Acid Therapy in Patients with Primary Biliary Cholangitis with Limited Liver Transplantation Availability. (2017/05/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis. (2017/04/26) ♡
• A genome-wide association study identifies six novel risk loci for primary biliary cholangitis. (2017/04/20) ♡
• Diagnosis and Treatment of Autoimmune Liver Diseases in a Tertiary Referral Center in Cuba. (2017/04/07) ♡
• Hepatic Inflammation May Influence Liver Stiffness Measurements by Transient Elastography in Children and Young Adults. (2017/04/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis: First case in a context of autoimmunity and hypovitaminosis D]. (2017/04/01) ♡
• Predictive Equations Are Inaccurate in the Estimation of the Resting Energy Expenditure of Children With End-Stage Liver Disease. (2017/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Assessment of Hepatic Impairment and Implications for Pharmacokinetics of Substance Use Treatment. (2017/03/01) ♡
• Cholecystolithotomy Combined Armillarisin A versus Cholecystectomy in Cirrhotic Portal Hypertension Patients with Symptomatic Cholelithiasis. (2017/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. To screen or not to screen? Celiac antibodies in liver diseases. (2017/02/07) ♡
• Histone deacetylase 9 plays a role in the antifibrogenic effect of astaxanthin in hepatic stellate cells. (2017/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The ascending pathophysiology of cholestatic liver disease. (2017/02/01) ♡
• Early Posthepatoportoenterostomy Predictors of Native Liver Survival in Biliary Atresia. (2017/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cholangiocarcinoma: Current Knowledge and New Developments. (2017/01/15) ♡
• Huang Qi Decoction Prevents BDL-Induced Liver Fibrosis Through Inhibition of Notch Signaling Activation. (2017/01/01) ♡
• Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge. (2017/01/01) ♡
• Ursodeoxycholic Acid Ameliorates Intrahepatic Cholestasis Independent of Biliary Bicarbonate Secretion in Vil2(kd/kd) Mice. (2017/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Current status and issues of liver transplantation for decompensated liver cirrhosis]. (2017/01/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Effect of Huagantongluofang, a Chinese Traditional Medicine, in Hepatic Fibrogenesis in a Mouse Model of Biliary Cirrhosis. (2017/01/01) ♡
• Microarray Expression Profile of Circular RNAs in Plasma from Primary Biliary Cholangitis Patients. (2017/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Gallstone Pancreatitis: A Common but Often Overlooked Cause of Abdominal Pain in Post-Liver-Transplant Patients. (2017/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Liver Disease in Sri Lanka. (2017/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Mesenchymal Stem Cells as New Therapeutic Agents for the Treatment of Primary Biliary Cholangitis. (2017/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. NPDT Evaluation in Children With CFTR and (PSC) (2017-12-13) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis (2017-10-26) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus (2017-08-01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study Of Ursolic Acid For Primary Sclerosing Cholangitis (2017-07-25) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. SAMe to Treat Biliary Cirrhosis Symptoms (2017-07-02) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Initial Study of Rituximab to Treat Primary Biliary Cirrhosis (2017-07-02) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis (2017-05-31) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis (2017-05-23) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis (2017-03-28) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis (2017-03-28) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis (2017-03-28) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Efficacy and Safety of Vedolizumab Intravenous (IV) in the Treatment of Primary Sclerosing Cholangitis in Subjects With Underlying Inflammatory Bowel Disease (2017-03-08) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. IBAT Inhibitor A4250 for Cholestatic Pruritus (2017-02-23) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease (2017-02-17) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis (2017-01-13) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin (2016-11-15) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis (2016-09-27) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Fuzhenghuayu for Patients With PBC Who Had An Inadequate Response to Ursodeoxycholic Acid (2016-09-27) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis (2016-09-07) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pilot Study of FFP104 Dose Escalation in PBC Subjects (2016-08-24) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis (2016-08-03) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis (2016-07-14) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study of Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic Acid (2016-06-20) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. High-protein High-fiber Diet in Patients With Primary Biliary Cirrhosis (2016-06-08) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin (2016-05-18) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.